Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells

Our results show that using an EBV-LCL feeder cell line, large numbers of pure populations of highly activated NK cells can be expanded ex vivo under GMP conditions. With the exception of thyroiditis and constitutional symptoms related to IL-2 therapy, infusions of up to 1 x 10(8) cells/kg of ex viv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundqvist, Andreas, Berg, Maria, Smith, Aleah, Childs, Richard W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133963/
https://www.ncbi.nlm.nih.gov/pubmed/21750690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133963/
https://www.ncbi.nlm.nih.gov/pubmed/21750690

Ejemplares similares